Equinix (EQIX)

NASDAQReal EstateReit - SpecialtySnapshot 2026-10-15

$985.98-1.03%

Close 2026-10-16 · 1-day change

Read the published Living FV report summary

Investment OutlookAs of Oct 15, 2026

What could strengthen or challenge Equinix’s outlook?

The long-term thesis, the evidence coming in, and the environment around it. Thesis dated Jul 8, 2026.

Higher potential upsideImproving expectations

Next-FY EPS estimate change · 30 days

+1.0%

+10% or more+5%0%−5%−10% or less

18.80 → 18.99 EPS · FY ending Dec 31, 2027 · 13 analysts

Higher risk of downsideWeakening expectations

One observable signal. This measures changing earnings expectations, not the probability of a gain or loss.

How this is measured

Change in the same fiscal period’s mean EPS estimate from Sep 15, 2026 to Oct 15, 2026: (new ÷ prior − 1). Contributor count changed from 12 to 13; this is not the number of analysts revising. Source: FMP consensus snapshots. The ±10% axis is a display range.

Living FV™

Living Fair Value by QuarterlyIQ

A valuation that evolves as the business changes.

A published Living FV snapshot is not available yet. The valuation workflow remains discoverable; a market target cannot supply the missing evidence.

View Living FV report and workflow

What the Thesis Depends On

4 key conditions need to be met for the investment thesis to play out.

Key Factor	Why It Matters	Current Status	Break Condition	Latest Evidence
Grow dividends per share by 8% annually	Profit per share is guided to rise to about $42.7 in 2026.	Intact	Dividend growth falls below 5% annually	Dividend per share: $5.16 per share FY2026-Q2; GAAP. Published target: >=8% annual dividend growth. Target and observation units differ. Source published Jul 29, 20265.16 USD/share · source valueSource reportLast status assessment Oct 15, 2026 Measurement source consolidated · GAAP FY2026-Q2 · Period ending Jun 30, 2026 Source: company_financial_results. Reference: 04860230-8162-4e28-808d-46ba7199290e. Source status: eligible. Compare required operating outcomes Compare scope, accounting basis and period before treating this evidence as progress against an annual requirement.
EPS near $42.7 per share in 2026	Profit per share is guided to rise to about $42.7 in 2026.	Intact	EPS falls below $40 per share in FY26	Diluted EPS: $4.83 per share FY2026-Q2; GAAP. Published target: ~42.7 USD per share. Target period is not explicitly aligned with this observation. Source published Jul 29, 20264.83 USD/share · source valueSource reportLast status assessment Oct 15, 2026 Measurement source consolidated · GAAP FY2026-Q2 · Period ending Jun 30, 2026 Source: company_financial_results. Reference: 04860230-8162-4e28-808d-46ba7199290e. Source status: eligible. Compare required operating outcomes Compare scope, accounting basis and period before treating this evidence as progress against an annual requirement.
Strengthen AI infrastructure partnerships	A supporting condition in Equinix's published investment case. The stated target is Maintain or expand AI-related partnerships.	Intact	Loss of key AI partnerships or weakening AI demand	Qualitative: AI partnerships expanding Equinix joins AI capex race; positions to benefit from exponential data growth and early-stage enterprise AI demand. Context reviewed through Oct 15, 2026Last status assessment Oct 15, 2026Compare required operating outcomes Compare scope, accounting basis and period before treating this evidence as progress against an annual requirement.
Annual revenue growth near 10%	A primary condition in Equinix's published investment case. The stated target is >=10% YoY.	Intact	YoY revenue growth falls below 7% in FY26	Revenue growth: 16.36% FY2026-Q2; GAAP. Published target: >=10% YoY. Target period is not explicitly aligned with this observation. Source published Jul 29, 202616.356383 percent · calculatedSource reportLast status assessment Oct 15, 2026 Measurement source consolidated · GAAP FY2026-Q2 · Period ending Jun 30, 2026 Source: company_financial_results. Reference: 04860230-8162-4e28-808d-46ba7199290e. Source status: eligible. Compare required operating outcomes Compare scope, accounting basis and period before treating this evidence as progress against an annual requirement.

Stored thesis · Jul 8, 2026. Latest Evidence uses source-matched measurements where available, alongside the last thesis-monitor assessment. Source periods and assessment dates are shown separately. A new measurement does not automatically change the published status or verify an older target.

Incoming Evidence

Compare these dated observations with the operating requirements above

Expectations trend

Same fiscal period

FY2027 · fiscal year ending 2027-12-31 · fmp

FY2027 EPS$18.99

$19.31 → $18.99 · observed estimates

FY2027 revenue$11.39B

$11.28B → $11.39B · observed estimates

Exact estimates & source dates

One fiscal period and provider throughout. At least five contributors are required for each plotted metric; missing coverage stays a gap. Axes show the observed range. Counts measure coverage, not revisions.

FY2027 estimate observations · fmp
Snapshot	EPS	Revenue	EPS / revenue analysts
2026-07-24	$19.31	$11,283,878,710	6 / 28
2026-07-25	$19.31	$11,283,878,710	6 / 28
2026-07-26	$19.31	$11,283,878,710	6 / 28
2026-07-27	$19.31	$11,283,878,710	6 / 28
2026-07-28	$18.99	$11,268,179,457	12 / 21
2026-07-29	$18.99	$11,268,179,457	12 / 21
2026-07-30	$18.99	$11,268,179,457	12 / 21
2026-07-31	$18.63	$11,369,653,030	7 / 28
2026-08-01	$18.83	$11,354,978,429	12 / 21
2026-08-02	$18.63	$11,371,131,610	7 / 28
2026-08-03	$18.83	$11,358,904,355	12 / 21
2026-08-04	$18.83	$11,358,904,355	12 / 21
2026-08-05	$18.63	$11,386,383,060	7 / 28
2026-08-06	$18.83	$11,358,904,355	12 / 21
2026-08-07	$18.83	$11,358,904,355	12 / 21
2026-08-08	$18.88	$11,387,840,880	6 / 28
2026-08-09	$18.88	$11,387,840,880	6 / 28
2026-08-10	$18.83	$11,358,904,355	12 / 21
2026-08-11	$18.88	$11,387,840,880	6 / 28
2026-08-12	$18.88	$11,387,840,880	6 / 28
2026-08-13	$18.88	$11,387,840,880	6 / 28
2026-08-14	$18.83	$11,358,904,355	12 / 21
2026-08-15	$18.83	$11,358,904,355	12 / 21
2026-08-16	$18.83	$11,358,904,355	12 / 21
2026-08-17	$18.83	$11,358,904,355	12 / 21
2026-08-18	$18.83	$11,358,904,355	12 / 21
2026-08-19	$18.83	$11,358,904,355	12 / 21
2026-08-20	$18.84	$11,360,291,413	12 / 21
2026-08-21	$18.84	$11,360,571,204	12 / 21
2026-08-22	$18.84	$11,360,571,204	12 / 21
2026-08-23	$18.84	$11,360,571,204	12 / 21
2026-08-24	$18.84	$11,360,571,204	12 / 21
2026-08-25	$18.84	$11,360,571,204	12 / 21
2026-08-26	$18.84	$11,360,571,204	12 / 21
2026-08-27	$18.84	$11,360,571,204	12 / 21
2026-08-28	$18.84	$11,360,571,204	12 / 21
2026-08-29	$18.84	$11,360,571,204	12 / 21
2026-08-30	$18.84	$11,360,571,204	12 / 21
2026-08-31	$18.84	$11,360,571,204	12 / 21
2026-09-01	$18.84	$11,360,571,204	12 / 21
2026-09-02	$18.84	$11,360,571,204	12 / 21
2026-09-03	$18.84	$11,360,571,204	12 / 21
2026-09-04	$18.84	$11,360,571,204	12 / 21
2026-09-05	$18.84	$11,360,571,204	12 / 21
2026-09-06	$18.80	$11,360,571,204	12 / 21
2026-09-07	$18.80	$11,360,571,204	12 / 21
2026-09-08	$18.80	$11,360,571,204	12 / 21
2026-09-09	$18.80	$11,360,571,204	12 / 21
2026-09-10	$18.80	$11,360,571,204	12 / 21
2026-09-11	$18.80	$11,362,736,722	12 / 21
2026-09-12	$18.80	$11,362,736,722	12 / 21
2026-09-13	$18.80	$11,362,736,722	12 / 21
2026-09-14	$18.80	$11,362,736,722	12 / 22
2026-09-15	$18.80	$11,362,736,722	12 / 22
2026-09-16	$18.80	$11,362,736,722	12 / 22
2026-09-17	$18.80	$11,362,736,722	12 / 22
2026-09-18	$18.80	$11,362,736,722	12 / 22
2026-09-19	$18.80	$11,362,736,722	13 / 22
2026-09-20	$18.80	$11,362,736,722	13 / 22
2026-09-21	$18.80	$11,362,736,722	13 / 22
2026-09-22	$18.84	$11,377,604,973	13 / 22
2026-09-23	$18.84	$11,377,604,973	13 / 22
2026-09-24	$18.82	$11,377,619,874	13 / 22
2026-09-25	$18.82	$11,377,619,874	13 / 22
2026-09-26	$18.82	$11,377,619,874	13 / 22
2026-09-27	$18.82	$11,377,619,874	13 / 22
2026-09-28	$18.82	$11,377,619,874	13 / 22
2026-09-29	$18.82	$11,377,619,874	13 / 22
2026-09-30	$18.82	$11,377,619,874	13 / 22
2026-10-01	$18.82	$11,377,619,874	13 / 22
2026-10-02	$18.82	$11,377,619,874	13 / 22
2026-10-03	$18.82	$11,377,619,874	13 / 22
2026-10-04	$18.82	$11,377,619,874	13 / 22
2026-10-05	$18.82	$11,377,619,874	13 / 22
2026-10-06	$18.82	$11,377,619,874	13 / 22
2026-10-07	$18.79	$11,384,286,540	13 / 22
2026-10-08	$18.79	$11,384,286,540	13 / 22
2026-10-09	$18.99	$11,387,576,540	13 / 22
2026-10-10	$18.99	$11,387,576,540	13 / 22
2026-10-11	$18.99	$11,387,576,540	13 / 22
2026-10-12	$18.99	$11,387,576,540	13 / 22
2026-10-13	$18.99	$11,387,576,540	13 / 22
2026-10-14	$18.99	$11,387,576,540	13 / 22
2026-10-15	$18.99	$11,387,576,540	13 / 22

Revenue and EPS estimates track expectations. They are not delivered results or like-for-like proof of a required annual path.

Compare required revenue and earnings

Analyst view

Monthly observations

Buy / Strong BuyHoldSell / Strong Sell

Exact monthly counts

Monthly rating snapshots · fmp. Missing snapshots are not zero.
Date	Buy*	Hold	Sell*
2026-05-01	26	6	1
2026-06-01	25	5	1
2026-07-01	26	6	1
2026-08-01	27	6	0
2026-09-01	28	6	0
2026-10-01	28	6	0

*Buy includes Strong Buy; Sell includes Strong Sell. Monthly counts describe the analyst mix, not the firms behind each recent action.

Latest: 28 Buy / Strong Buy · 6 Hold · 0 Sell / Strong Sell

0 upgrades0 downgrades0 maintains

Recent actions · Sep 16–Oct 15 · 0 recorded

Price-target changes

30 days

○ Previous · ● Latest · common dollar scale

Redburn PartnersSep 21

$1261.00New observation · no comparable prior

$0$693.55$1387.10

0 raises · 0 cuts · 0 unchanged · 1 without a comparable prior

How this is measured

Sep 16, 2026–Oct 15, 2026. Each firm's latest positive target is paired only with its immediately prior positive target from the same provider, at most 180 days earlier. Unmatched observations have one dot; conflicting observations are not compared.

Outlook in Brief

The evidence, the remaining questions, and what comes next

What's improving

No recovery evidence is reported in the available driver assessments.

Still unresolved / key risks

Grow dividends per share by 8% annuallyDividend per share: $5.16 per share
EPS near $42.7 per share in 2026Diluted EPS: $4.83 per share
Annual revenue growth near 10%Revenue growth: 16.36%

Next proof point

Oct 28, 2026

Look for updated results and guidance against the published targets, plus direct evidence for unresolved drivers.

Review earnings

Bottom line

3 of 4 published conditions remain under pressure or need verification. The next results need to address those conditions.

The dated weekly assessment and its assumptions are available in Read detailed Outlook.

Historical risk context

Observed price history; separate from operating scenarios

Price sensitivity

1.1%Typical daily move · historical

Downside history

-13.7%Maximum drawdown · trailing year

Read detailed Outlook Company context, assumptions & risks

Equinix outlook in detail

The weekly editorial context below is a separate assessment from the dated monitor evidence above. Recovery observations do not automatically change the published thesis. Unverified outside influences are hypotheses, not measured driver evidence.

Updated Oct 10, 2026

What kind of bet this is

This investment represents a durable compounder with a focus on consistent revenue and dividend growth. The current thesis state is intact, supported by strong recent financial performance and management's commitment to growth targets.

What's priced into Equinix

The market currently prices EQIX at a premium compared to peers, reflecting justified expectations for continued growth. There is a small expectations gap, indicating that some positive performance is already anticipated.

What the fundamentals likely do

Management is on track to achieve its revenue growth and margin expansion goals, which should support ongoing strong financial performance. However, there is a moderate risk of missing guidance, which could negatively impact sentiment.

What Equinix hinges on

The long-term thesis hinges on the Federal Reserve's interest rate decisions and the performance of sector peers. Positive earnings reports from major competitors could provide momentum, while any guidance cuts from EQIX would likely lead to a decline in estimates.